Results 21 to 30 of about 9,820 (188)

Dual 1550-nm Erbium Glass Fiber and 1927-nm Thulium Fiber Non-ablative Fractional Laser System Treatment in Patients With Skin of Color: A Review of Clinical Studies and Unmet Needs. [PDF]

open access: yesLasers Surg Med
ABSTRACT Objectives To review the efficacy and safety of the dual 1550‐nm erbium glass fiber and 1927‐nm thulium fiber non‐ablative fractional laser system in patients with skin of color (ie, Fitzpatrick skin types [FSTs] III–VI). Materials and Methods Efficacy, safety, and histologic outcomes were reviewed from 15 clinical studies examining the use of
Goldman MP   +5 more
europepmc   +2 more sources

Melasma Update

open access: yesActas Dermo-Sifiliográficas, 2009
Melasma is a common acquired hyperpigmentary disorder of the face. However, the pathogenesis of melasma remains largely unknown and the treatment is still challenging. This article discusses histology of melasma in view of melanin pigmentation with a more in depth question about number of melanocytes and melanophages in dermis of melasma.
H, Young Kang, J-P, Ortonne
openaire   +2 more sources

The Description of Dermoscopy and Wood’s Lamp on Melasma

open access: yesBerkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2017
Background: Melasma is an acquired hypermelanosis disorder occurred symmetrically on the sun exposure area, predominantly on the face and neck. Melasma classification based on Wood’s light examination does not always have positive correlation with the ...
Ryski Meilia Novarina   +2 more
doaj   +1 more source

Melasma update

open access: yesIndian Dermatology Online Journal, 2014
Melasma is an acquired pigmentary disorder characterized by symmetrical hyperpigmented macules on the face. Its pathogenesis is complex and involves the interplay of various factors such as genetic predisposition, ultraviolet radiation, hormonal factors, and drugs.
Rashmi Sarkar   +4 more
openaire   +3 more sources

Melasma

open access: yesSKINmed: Dermatology for the Clinician, 2007
-
  +6 more sources

New oral and topical approaches for the treatment of melasma

open access: yesInternational Journal of Women's Dermatology, 2019
Melasma is a common, therapeutically challenging, and universally relapsing disorder of hyperpigmentation that is most often observed in women and individuals with Fitzpatrick Skin Types III through VI. The pathogenesis of melasma is complex and protean.
P.E. Grimes, MD   +3 more
doaj   +1 more source

The effect of melasma on self-esteem: A pilot study

open access: yesInternational Journal of Women's Dermatology, 2018
Melasma is a common disorder of hyperpigmentation characterized by tan or brown macules and patches affecting sun-exposed areas, particularly the face.
J. Jiang   +3 more
doaj   +1 more source

Oral tranexamic acid for the treatment of melasma: evidence and experience-based consensus statement from Indian experts

open access: yesIndian Journal of Dermatology, 2023
Melasma, a chronic pigmentary skin condition mainly affecting the face, remains a challenge despite the availability of several options for treatment. Many melasma patients are not satisfied with treatment outcomes.
Kiran Godse   +12 more
doaj   +1 more source

Is Topical Zinc Effective in the Treatment of Melasma? A Double-Blind Randomized Comparative Study [PDF]

open access: yes, 2014
Background and ObjectivesZinc plays a role in skin health, and preliminary data have shown its beneficial effects for melasma. We compared the effect of topical zinc with that of hydroquinone as the standard treatment on severity of melasma. Patients and
Eskandari, Yasaman.   +5 more
core   +1 more source

A hospital-based cross-sectional study of clinical, wood's lamp, and dermoscopic findings in melasma

open access: yesClinical Dermatology Review, 2023
Background: Melasma is a common pigmentation disorder with female predominance. Depending on melanin depth, it can be epidermal, dermal, and mixed type. Assessment of this helps to chalk out a proper treatment plan.
P M Amrutha Herle   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy